Autores: Walter Alfredo Goycochea-Valdivia (Infectología Pediátrica, UGC Pediatría), Elia Sánchez Valderrábanos (CIUP), José Miguel Cisneros (UCEIMP), José Molina (UCEIMP), Ángel Rodríguez Villodres (UCEIMP), José Antonio Lepe (UCEIMP), Guillermo Martín Gutierrez (UCEIMP), María Victoria Gil Navarro (UGC Farmacia), Marta Moleón (UGC Farmacia), María Dolores Falcon Neyra (Infectología Pediátrica, UGC Pediatría), María José Muñoz Vilchez (Infectología Pediátrica, UCG Pediatría), Olaf Neth (Infectología Pediátrica, UGC Pediatría).
Bibliografía:
- Mical Paul, Elena Carrara, Pilar Retamar, Thomas Tängdén, Roni Bitterman, Robert A. Bonomo, Jan de Waele, George L. Daikos, Murat Akova, Stephan Harbarth, Celine Pulcini, José Garnacho-Montero, Katja Seme, Mario Tumbarello, Paul Christoffer Lindemann, Sumanth Gandra, Yunsong Yu, Matteo Bassetti, Johan W. Mouton, Evelina Tacconelli, Jesús Rodríguez-Baño. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clinical Microbiology and Infection, Volume 28, Issue 4, 2022, Pages 521-547, ISSN 1198-743X. https://doi.org/10.1016/j.cmi.2021.11.025.
- Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections. Infectious Diseases Society of America 2022; Version 2.0. Available at https://www.idsociety.org/practice-guideline/amr-guidance-2.0/. Accessed 24 September, 2022.
- Aguilera-Alonso D, Escosa-García L, Goycochea-Valdivia WA, Soler-Palacín P, Saavedra-Lozano J, Rodrigo C, Cercenado E, Ramos JT, Baquero-Artigao F. Documento de posicionamiento de la Asociación Española de Pediatría-Sociedad Española de Infectología Pediátrica (AEP-SEIP) sobre el tratamiento de las infecciones por bacterias multirresistentes [Position statement of the Spanish Association of Paediatrics-Spanish Society of Paediatric Infectious Diseases (AEP-SEIP) on the treatment of multidrug-resistant bacterial infections]. An Pediatr (Engl Ed). 2019 Nov;91(5):351.e1-351.e13. Spanish. doi: 10.1016/j.anpedi.2019.08.002. Epub 2019 Oct 19. PMID: 31635925.
- Chiusaroli L, Liberati C, Caseti M, Rulli L, Barbieri E, Giaquinto C, Donà D. Therapeutic Options and Outcomes for the Treatment of Neonates and Preterms with Gram-Negative Multidrug-Resistant Bacteria: A Systematic Review. Antibiotics (Basel). 2022 Aug 10;11(8):1088. doi: 10.3390/antibiotics11081088. PMID: 36009956; PMCID: PMC9404799.
- De Luca M, Angelino G, Calò Carducci FI, Martino A, Bernardi S, Bernaschi P, Carletti M, D’Argenio P, Palma P. Multidrug-resistant Acinetobacter baumannii infection in children. BMJ Case Rep. 2011 Aug 11;2011:bcr0220113807. doi: 10.1136/bcr.02.2011.3807. PMID: 22688471; PMCID: PMC3158346.
- Sayyahfar S, Choobdar FA, Mashayekhi M, Jazi FM. Successful Management of Pan-Resistant Acinetobacter baumannii Meningitis without Intrathecal or Intraventricular Antibiotic Therapy in a Neonate. Infect Chemother. 2021 Mar;53(1):146-150.
- Ghunaim AH, Alghamdi AM, Alghamd, EM, Aldabbagh M. Successful treatment of Acinetobacter baumannii infection in Burn Child with Avibactam/Sulbactam: A Case Report. Ann Clin Case Rep. 2022; 7: 2247. ISSN: 2474-165
- SEIP: Dosis de antibióticos. Versión 1.0 -15/03/2021. https://www.seipweb.es/wp-content/uploads/2021/03/Tabla-dosis-antibioticos-pediatria.-v.1.0.pdf. Acceso 24 de Septiembre del 2022.